MX2020002321A - Composición que contiene un análogo de kaempferol. - Google Patents

Composición que contiene un análogo de kaempferol.

Info

Publication number
MX2020002321A
MX2020002321A MX2020002321A MX2020002321A MX2020002321A MX 2020002321 A MX2020002321 A MX 2020002321A MX 2020002321 A MX2020002321 A MX 2020002321A MX 2020002321 A MX2020002321 A MX 2020002321A MX 2020002321 A MX2020002321 A MX 2020002321A
Authority
MX
Mexico
Prior art keywords
containing composition
kaempferol analog
kaempferol
analog
composition
Prior art date
Application number
MX2020002321A
Other languages
English (en)
Inventor
Yasutaka Ikeda
Tsubasa Mizokami
Yasuhiro Abiru
Minoru Akiyama
Ayuko Oyama
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of MX2020002321A publication Critical patent/MX2020002321A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/03Organic compounds
    • A23L29/035Organic compounds containing oxygen as heteroatom
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11Plant sterols or derivatives thereof, e.g. phytosterols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/21Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/31Foods, ingredients or supplements having a functional effect on health having an effect on comfort perception and well-being
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/316Foods, ingredients or supplements having a functional effect on health having an effect on regeneration or building of ligaments or muscles
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/20Natural extracts
    • A23V2250/21Plant extracts
    • A23V2250/2116Flavonoids, isoflavones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Amplifiers (AREA)

Abstract

La presente solicitud proporciona una composición para mejorar la eficiencia de la actividad física, una composición para reducir la fatiga, y una composición para mejorar la agudeza visual dinámica/cinética, que comprende un análogo de kaempferol.
MX2020002321A 2017-08-30 2018-08-30 Composición que contiene un análogo de kaempferol. MX2020002321A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/JP2017/031214 WO2019043846A1 (ja) 2017-08-30 2017-08-30 ケンペロール類縁体含有組成物
PCT/JP2018/032104 WO2019044964A1 (ja) 2017-08-30 2018-08-30 ケンペロール類縁体含有組成物

Publications (1)

Publication Number Publication Date
MX2020002321A true MX2020002321A (es) 2020-10-05

Family

ID=65525082

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020002321A MX2020002321A (es) 2017-08-30 2018-08-30 Composición que contiene un análogo de kaempferol.

Country Status (12)

Country Link
US (2) US20200323816A1 (es)
EP (1) EP3677262A4 (es)
JP (2) JP7372149B2 (es)
KR (1) KR20200050980A (es)
CN (1) CN111032037A (es)
AU (2) AU2018327188B2 (es)
BR (1) BR112020003933A2 (es)
CA (1) CA3073804A1 (es)
MX (1) MX2020002321A (es)
SG (1) SG11202001653QA (es)
TW (1) TWI845480B (es)
WO (2) WO2019043846A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019043846A1 (ja) 2017-08-30 2019-03-07 大塚製薬株式会社 ケンペロール類縁体含有組成物
JPWO2020175579A1 (ja) * 2019-02-27 2021-12-23 大塚製薬株式会社 植物由来エキス及び/又は植物由来加工品含有組成物
JP7367956B2 (ja) * 2019-07-05 2023-10-24 国立大学法人大阪大学 動体視力向上用組成物
KR20230057405A (ko) 2020-08-25 2023-04-28 오츠카 세이야쿠 가부시키가이샤 캠페롤 아글리콘 함유 추출물
WO2022269931A1 (ja) * 2021-06-25 2022-12-29 大塚製薬株式会社 筋損傷抑制用組成物

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060111318A1 (en) * 2003-04-18 2006-05-25 Advanced Medicine Research Institute Agent for treating eye diseases
JP2006298876A (ja) * 2005-04-25 2006-11-02 Saisentan Igaku Kenkyusho:Kk サーチュインの活性化剤を含む各種眼疾患治療用組成物
US20060222682A1 (en) 2005-03-18 2006-10-05 Andrews David A Nutraceutical Moringa composition
CN103055313A (zh) 2005-07-07 2013-04-24 西特里斯药业公司 用于治疗或预防肥胖、胰岛素抵抗障碍和线粒体相关障碍的方法和相关组合物
CN101257897A (zh) * 2005-07-07 2008-09-03 西特里斯药业公司 用于治疗或预防肥胖、胰岛素抵抗障碍和线粒体相关障碍的方法和相关组合物
JP5066706B2 (ja) 2006-02-28 2012-11-07 国立大学法人徳島大学 抗肥満剤のスクリーニング方法
JP5061282B2 (ja) * 2006-07-10 2012-10-31 株式会社 伊藤園 ナリンゲニン誘導体、それを含有するグルコース取込み促進剤及び血糖値上昇抑制剤
JP5713332B2 (ja) * 2007-02-23 2015-05-07 ユニチカ株式会社 抗疲労用組成物
JP2009155333A (ja) 2009-01-13 2009-07-16 Tsujido Chemical Corp 抗疲労剤
WO2010086972A1 (ja) 2009-01-28 2010-08-05 Sekiyama Atsuo 抗ストレス剤
KR101177786B1 (ko) 2010-02-26 2012-08-30 박영주 꿀벌 화분 발효액, 프로폴리스, 벌꿀 및 로얄 제리를 함유하는 건강식품의 제조 방법
CA2808530A1 (en) * 2010-09-17 2012-03-22 Stokely-Van Camp, Inc. Methods of reducing blood lactate concentration
CN102600269A (zh) 2011-01-19 2012-07-25 江苏中康药物科技有限公司 一种含异长春花苷内酰胺的胆木叶组合物及其制剂与用途
CN102138998B (zh) 2011-04-08 2013-04-24 中国人民解放军总后勤部卫生部药品仪器检验所 枳椇子总黄酮提取物及其在制备抗疲劳、抗缺氧或抗高原缺氧药物或食品中的应用
JP2012236793A (ja) * 2011-05-11 2012-12-06 Kikkoman Corp Ampk活性化剤
US20140107193A1 (en) 2011-10-14 2014-04-17 Mead Johnson Nutrition Company Nutritional composition containing a neurologic component of kaempferol and/or fisetin and uses thereof
KR101454425B1 (ko) * 2012-10-11 2014-11-03 포항공과대학교 산학협력단 미리세틴을 유효성분으로 포함하는 운동수행능력 증강용 조성물
JPWO2014171333A1 (ja) 2013-04-17 2017-02-23 株式会社フローラ ミトコンドリア活性化剤
CN104223068B (zh) * 2014-09-05 2016-09-21 杨高林 一种补肝益肾明目的沙苑子口服液及其制备方法
US20180071273A1 (en) * 2015-03-17 2018-03-15 Speccialty Nutrition Group, Inc. Nutritional compositions to enhance mitochondrial energy production
JP6751709B2 (ja) * 2015-04-10 2020-09-09 オリザ油化株式会社 筋肉細胞におけるエネルギー代謝活性化剤
EP3352774A4 (en) * 2015-09-23 2019-04-03 Reoxcyn, LLC FLAVONOID COMPOSITIONS AND METHODS OF USE
EP3360548A4 (en) 2015-10-08 2019-06-19 Productive Aging Laboratory, Co., Ltd. INHIBITOR OF MUSCLE DENSION OR MUSCLE FATIGUE
TW201733619A (zh) * 2015-12-16 2017-10-01 Suntory Holdings Ltd 肌肽二肽酶阻礙用組成物
WO2019043846A1 (ja) 2017-08-30 2019-03-07 大塚製薬株式会社 ケンペロール類縁体含有組成物
CN112568425A (zh) 2019-09-30 2021-03-30 中粮营养健康研究院有限公司 能量棒及其制备方法和在制备抗肌肉损伤的产品中的应用

Also Published As

Publication number Publication date
AU2024216546A1 (en) 2024-09-19
BR112020003933A2 (pt) 2020-09-08
SG11202001653QA (en) 2020-03-30
TW201912154A (zh) 2019-04-01
EP3677262A4 (en) 2021-05-26
AU2018327188B2 (en) 2024-08-08
JPWO2019044964A1 (ja) 2020-10-08
US20200323816A1 (en) 2020-10-15
KR20200050980A (ko) 2020-05-12
JP7372149B2 (ja) 2023-10-31
US12048683B2 (en) 2024-07-30
CN111032037A (zh) 2020-04-17
JP2023126878A (ja) 2023-09-12
EP3677262A1 (en) 2020-07-08
TWI845480B (zh) 2024-06-21
US20210228540A1 (en) 2021-07-29
WO2019044964A1 (ja) 2019-03-07
WO2019043846A1 (ja) 2019-03-07
CA3073804A1 (en) 2019-03-07
AU2018327188A1 (en) 2020-03-19

Similar Documents

Publication Publication Date Title
PL3668937T3 (pl) Kompozycje i zastosowania Z-1-chloro-2,3,3,3-tetrafluoroprop-1-enu
MX2020002321A (es) Composición que contiene un análogo de kaempferol.
MX2019007020A (es) Anticuerpos il-11.
MX2019007021A (es) Anticuerpos il-11ra.
SG10201803042PA (en) Anti-tim-3 antibodies
JOP20170055B1 (ar) تركيبة شراب تحتوي على اليولوز وطعام يحتوي على التركيبة
GB201712273D0 (en) The P.I.R. Co. Ltd - business model
SG11202011685QA (en) 2,3-dihydro-1h-pyrrolizine-7-formamide derivative and application thereof
IL272055A (en) 8,1-naphthyridinone compounds and their uses
MX2017008390A (es) Uretanos funcionalizados con alcoxisilano y funcionalizados con alofanato.
MX2019010950A (es) Composicion de fotosensibilizador que contiene fenalen-1-ona, compuesto de fenalen-1-ona, asi como su uso.
GB201901099D0 (en) Methods, uses and compositions
GB202017595D0 (en) Compositions, and methods and uses relating thereto
MX2019013250A (es) 2,3,7-trimetiloct-6-enil acetato y 3,7-dimetil-2-metilen-oct-6-eni l acetato y derivados de estos y su uso como sustancias quimicas aromaticas.
MX2021010346A (es) Composicion que contiene extracto derivado de plantas y/o producto procesado derivado de plantas.
MX2017013278A (es) Odorante osmanthus.
GB202015822D0 (en) 66.123.142648/01
ZA201906210B (en) Formulation of stearyl alcohol
WO2017087914A3 (en) Urea biosensors and uses thereof
PL3894381T3 (pl) Dodeka-4,8,11-trien-1-ol i jego zastosowania jako aromatowej substancji chemicznej
GB2579240B (en) New processes, compositions and medical uses
PL3692027T3 (pl) Aromatowe kompozycje chemiczne zawierające 3,5-dietylo-2-propylotetrahydropiran i/albo jego nienasycone pochodne
MX2017016814A (es) 2,4,7-trimetiloct-6-en-1-ol como ingrediente de fragancia.
MX2018005687A (es) Sazonador similar a salsa de soya.
MX2018008376A (es) Composiciones de fragancia de liberacion prolongada.